These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 16467816)

  • 1. No unfairness in funding of Croatian minister's project.
    Risović S
    Nature; 2006 Feb; 439(7077):660. PubMed ID: 16467816
    [No Abstract]   [Full Text] [Related]  

  • 2. Croatian scientists call for openness over funding.
    Abbott A
    Nature; 2006 Jan; 439(7072):7. PubMed ID: 16397469
    [No Abstract]   [Full Text] [Related]  

  • 3. Taking the industry road.
    Mejia R
    Nature; 2008 Jun; 453(7198):1138-9. PubMed ID: 18663783
    [No Abstract]   [Full Text] [Related]  

  • 4. Ethics. Private money, public disclosure.
    Kaiser J
    Science; 2009 Jul; 325(5936):28-30. PubMed ID: 19574366
    [No Abstract]   [Full Text] [Related]  

  • 5. RE: Secret ties to industry and conflicting interests in cancer research.
    Wakeford R
    Am J Ind Med; 2007 Mar; 50(3):239-40. PubMed ID: 17315183
    [No Abstract]   [Full Text] [Related]  

  • 6. Financial conflicts of interest and human subjects research.
    Maloney DM
    Hum Res Rep; 2002 Dec; 17(12):3. PubMed ID: 12731501
    [No Abstract]   [Full Text] [Related]  

  • 7. A rebuttal: secret ties to industry and conflicting interests in cancer research.
    McLaughlin JK; Boice JD; Tarone RE; Blot WJ
    Am J Ind Med; 2007 Mar; 50(3):235-6. PubMed ID: 17187382
    [No Abstract]   [Full Text] [Related]  

  • 8. Conservation biology: is this any way to save a species?
    Dalton R
    Nature; 2005 Jul; 436(7047):14-6. PubMed ID: 16001032
    [No Abstract]   [Full Text] [Related]  

  • 9. Surgery journal threatens ban for authors' hidden conflicts.
    Armstrong D
    Wall St J (East Ed); 2005 Dec; ():B1, B2. PubMed ID: 16502542
    [No Abstract]   [Full Text] [Related]  

  • 10. Conflict of interest in the debate over calcium-channel antagonists.
    Meltzer JI
    N Engl J Med; 1998 Jun; 338(23):1696; author reply 1697-8. PubMed ID: 9616063
    [No Abstract]   [Full Text] [Related]  

  • 11. Doubts over evolution block funding by Canadian agency.
    Hoag H
    Nature; 2006 Apr; 440(7085):720-1. PubMed ID: 16598216
    [No Abstract]   [Full Text] [Related]  

  • 12. Medical reviews face criticism over lapses.
    Armstrong D
    Wall St J (East Ed); 2006 Jul; ():B1, B2. PubMed ID: 16909499
    [No Abstract]   [Full Text] [Related]  

  • 13. Funding agencies toughen stance on open access.
    Ledford H
    Nature; 2006 Oct; 443(7114):894-5. PubMed ID: 17065998
    [No Abstract]   [Full Text] [Related]  

  • 14. Australian scientists protest at loss of funding board.
    Dennis C
    Nature; 2005 Jul; 436(7050):451. PubMed ID: 16049440
    [No Abstract]   [Full Text] [Related]  

  • 15. Ethics. Senate inquiry on research conflicts shifts to grantees.
    Kaiser J
    Science; 2008 Jun; 320(5884):1708. PubMed ID: 18583586
    [No Abstract]   [Full Text] [Related]  

  • 16. The hand that feeds.
    Nature; 2005 Sep; 437(7057):295. PubMed ID: 16163305
    [No Abstract]   [Full Text] [Related]  

  • 17. [For and against: does sponsoring impede the growth of knowledge in medicine?].
    Finzen A; Fritze J
    Psychiatr Prax; 2007 May; 34(4):162-4. PubMed ID: 17520527
    [No Abstract]   [Full Text] [Related]  

  • 18. RE: Secret ties to industry and conflicting interests in cancer research.
    Trichopoulos D; Adami HO
    Am J Ind Med; 2007 Mar; 50(3):237. PubMed ID: 17216628
    [No Abstract]   [Full Text] [Related]  

  • 19. Implicit demand characteristics in research funding sources--it's not just some sources.
    McLellan AT
    Addiction; 2007 Jul; 102(7):1035-7; discussion 1039-40. PubMed ID: 17567387
    [No Abstract]   [Full Text] [Related]  

  • 20. Bad funding.
    Nature; 2004 Nov; 432(7013):1. PubMed ID: 15525941
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.